Home > Boards > US OTC > Medical - Drugs >

NDT Pharmaceuticals Inc. (NDTP)

NDTP RSS Feed
Add NDTP Price Alert      Hide Sticky   Hide Intro
Moderator: Ecomike, flacrusher, ChaseDog31, Bivins, bobw1951
Search This Board: 
Last Post: 5/19/2022 12:36:56 AM - Followers: 176 - Board type: Free - Posts Today: 1

WELCOME To

NDT PHARMACEUTICALS, INC

New Website is Live at

http://www.NDTPharma.com

 

https://www.news-medical.net/news/20190212/Pill-that-reverses-brain-damage-could-be-on-the-horizon.aspx

 

"Researchers at the University of Pennsylvania have made important progress in designing a drug that could recover brain

function in cases of severe brain damage due to injury or diseases such as
Alzheimer’s."

 

By Sally Robertson, B.Sc.Feb 12 2019 Reviewed by Kate Anderton, B.Sc. (Editor)

 

https://www.researchgate.net/publication/331636495_Selective_Liposomal_Transport_Through_Blood_Brain_Barrier_Disruption_in_Ischaemic_Stroke_Reveals_Two_Distinct_Therapeutic_Opportunities

 
























Here is a look into the next frontier of Nanotech Bio-chemcial medicine coming to MILV






To understand what the Nano Tech R/M with MILV is all about, and why it is the future of medicine, pharmaceurticals, health

supplements and drinks one must understand what a Liposome is and how and why they are so usefull.

Here is link to an image Library of them with labels. Think of them nano probe drones that can navigate and deliver stuff the

right address in the the human body on demand.

 

https://liposomes.weebly.com/the-basics.html

 



Here is what the MILV / CCA partner University of Pennsylvania is working on.

 
 
 
 


 
 

20 years ago a prior company called the Liposome company,

that earlier Michael W Fountain patents and work was a big part of

what was bought for $585 Mil dollars in 2000 by ELAN Pharma...

 

https://www.thepharmaletter.com/article/elan-to-acquire-the-liposome-company


Methods of dehydrating, storing and rehydrating liposomes

 

Patent number: 5922350

Abstract: Dehydrated liposomes are prepared by drying liposome preparations under reduced pressure in the presence of one or more protective sugars, e.g., the disaccharides

trehalose and sucrose. Preferably, the protective sugars are present at both the inside and outside surfaces of the liposome membranes. Freezing of the liposome preparation

prior to dehydration is optional. Alternatively, the protective sugar can be omitted if: (1) the liposomes are of the type which have multiple lipid layers; (2) the dehydration is done

without prior freezing; and (3) the dehydration is performed to an end point which results in sufficient water being left in the preparation (e.g., at least 12 moles water/mole lipid)

so that the integrity of a substantial portion of the multiple lipid layers is retained upon rehydration.

Type: Grant

Filed: June 16, 1997

Date of Patent: July 13, 1999

Assignee: The Liposome Company, Inc.

Inventors: Andrew S. Janoff, Pieter R. Cullis, Marcel B. Bally, Michael W. Fountain, Richard S. Ginsberg, Michael J. Hope, Thomas D. Madden, Hugh P. Schieren, Regina L. Jablonski

Patent number: 4610868

Abstract: Lipid matrix carriers are described which provide for the sustained release of bioactive agents in vivo or in vitro. The properties

of the lipid matrix carriers of the present

invention include high entrapment efficiencies; release of entrapped compounds in their active form; biodegradability and avoidance of

vascular occlusion in vivo; and avoidance

of sequestration of the bioactive agent in the liver and spleen.

Type: Grant

Filed: March 20, 1984

Date of Patent: September 9, 1986

Assignee: The Liposome Company, Inc.

Inventors: Michael W. Fountain, Steven J. Weiss, John J. Kearns, Alan L. Weiner, Mircea C. Popescu

Patent number: 4588578

Abstract: A process for the preparation in a monophasic solvent system of a new type of lipid vesicles, called monophasic lipid vesicles

(MPVs). MPVs can be made to

encapsulate one or more bioactive agents. MPVs are stable during storage and can be used in vivo in the treatment of disease.

Type: Grant

Filed: August 8, 1983

Date of Patent: May 13, 1986

Assignee: The Liposome Company, Inc.

Inventors: Michael W. Fountain, Steven J. Weiss, Mircea C. Popescu

Patent number: 4522803

Abstract: A new and substantially improved type of lipid vesicle, called stable plurilamellar vesicles (SPLVs), are described, as well as the

process for making the same. SPLVs

are stable during storage and can be used in vivo for the sustained release of compounds and in the treatment of disease.

Type: Grant

Filed: March 24, 1983

Date of Patent: June 11, 1985

Assignee: The Liposome Company, Inc.

Inventors: Robert P. Lenk, Michael W. Fountain, Andrew S. Janoff, Marc J. Ostro, Micrea C. Popescu

 

Related Univ of Penn Patents that might be involved with the formation of NDT Pharmaceutcal Inc

 

https://patents.google.com/patent/US9149543B2/en

 

US4610868A - Lipid matrix carriers for use in drug delivery ...

 
 

Application number: US06/591,576; Inventor: Michael W. Fountain: Steven J. Weiss: John J. ... Liposome Co Inc; Original Assignee:

Liposome Co Inc; Priority date (The priority date is ... US20100098773A1 (en) *, 2008-09-26, 2010-04-22, The Trustees Of The

University Of Pennsylvania
, Polymer ... Non-Patent Citations (7) ...


Link:

https://patents.google.com/patent/US4610868A/en


Earlier Historical Info

The R/M Custodial Letter that first allerted us to what was R/M with MILV
Oct. 24, 2019




More to come shortly, check back soon

 




 
NDTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#11081  Sticky Note $MILV I think this could be of benefit! Aquahoya 01/21/20 08:31:09 AM
#19372   Hopefully the full story will be told soon flacrusher 05/20/22 10:48:06 AM
#19371   Or it was an error in the first Ecomike 05/19/22 12:36:56 AM
#19370   Looks like our long term liabilities of 218,740.00 peneforme 05/18/22 08:57:51 PM
#19369   Has anyone besides me actually read the NDTP Ecomike 05/18/22 01:25:09 AM
#19368   Updated attorney letter posted 5/14/22 on otcmarkets.com reflecting bobw1951 05/17/22 11:46:43 AM
#19367   The after hours bid and ask mean nothing. ChaseDog31 05/17/22 10:35:32 AM
#19366   Hmmm, very interesting... Hummingbird2 05/17/22 02:39:42 AM
#19365   interesting that the ask is now at $7.50 bobw1951 05/16/22 05:38:29 PM
#19364   They just added the 2021 financials to the Bivins 05/16/22 02:58:54 PM
#19363   As soon as it’s goes current there going Jim Paul 05/15/22 04:12:32 PM
#19362   Jim, do you know if the company plans Bivins 05/15/22 03:23:10 PM
#19361   Otcmarkets.com shows amended yearly and amended quarterly reports bobw1951 05/12/22 08:01:41 PM
#19360   Get Pink Current then Caveat removal Jim Paul 05/12/22 07:00:33 PM
#19359   quiet before the storm???? bobw1951 05/12/22 05:03:29 PM
#19358   Yes and there behind 2 to 3 weeks Jim Paul 05/09/22 07:28:16 PM
#19357   otcmarkets.com still report NDTP as CE as of bobw1951 05/09/22 07:03:54 PM
#19356   I like the sound of this. Perfect timing. Ecomike 05/06/22 09:53:27 AM
#19355   Nice, looking forward to $NDTP relisted, trading and Hummingbird2 05/05/22 02:59:16 AM
#19354   Is there any way to know of any bobw1951 05/05/22 12:59:32 AM
#19353   Point of Clarification: ChaseDog31 05/04/22 10:16:56 PM
#19352   Amended Annual Report as of 12/31/21 ChaseDog31 05/04/22 09:35:12 PM
#19351   The financial statements contained in the Information for ChaseDog31 05/04/22 09:14:09 PM
#19350   Things are moving fast now - and I bobw1951 05/04/22 02:48:25 PM
#19349   Indeed, the stadium lights are on now, with Ecomike 05/04/22 02:33:03 PM
#19348   Amended annual filed today on NDTP, so the Ecomike 05/04/22 01:57:11 PM
#19347   Attorney letter. Seem to be moving in Bivins 05/04/22 01:55:15 PM
#19346   Indeed, very interesting. Hummingbird2 05/03/22 11:07:21 PM
#19345   I did a little reading, and it would bobw1951 05/03/22 11:47:39 AM
#19344   as Artie Johnson of Laugh-In fame once said: bobw1951 05/03/22 10:27:12 AM
#19343   Shortable Stocks Hummingbird2 05/03/22 03:24:07 AM
#19342   otcmarkets.com still lists NDTP as CE as of bobw1951 05/02/22 01:36:24 PM
#19341   Spock also said, in The Undiscovered Country (think Ecomike 05/01/22 01:58:54 PM
#19340   Joe P filed the first quarter https://www.otcmarkets.com/otcapi/company/financ Jim Paul 04/29/22 07:41:45 PM
#19339   Next event may be either the 1st quarter Ecomike 04/29/22 06:16:10 PM
#19338   NDTP is still pink limited as of 3p,m bobw1951 04/29/22 05:57:54 PM
#19337   When will the CE be lifted? - Any estimates? bobw1951 04/29/22 12:43:14 PM
#19336   3,092 more shares stashed out behind the old ChaseDog31 04/29/22 10:05:39 AM
#19335   Don't forget Passalaqua was the custodian who cleaned ChaseDog31 04/29/22 09:05:36 AM
#19334   Jim, perhaps you can shed some light on ChaseDog31 04/29/22 08:57:27 AM
#19333   I am relieved - finally we have a bobw1951 04/29/22 01:03:21 AM
#19332   I am happy with this filing. All the flacrusher 04/28/22 10:07:10 PM
#19331   Our balance sheet is as clean as a ChaseDog31 04/28/22 09:38:49 PM
#19330   We have assets! ChaseDog31 04/28/22 09:36:47 PM
#19329   Well this is interesting. The guy who signed ChaseDog31 04/28/22 09:28:03 PM
#19328   Passalaqua is listed as the director and sole ChaseDog31 04/28/22 09:24:11 PM
#19327   The Intellectual Property includes a versatile and widely ChaseDog31 04/28/22 09:18:26 PM
#19326   Says right in this filing they are attempting ChaseDog31 04/28/22 09:16:48 PM
#19325   This financial statement was prepared by Passalaqua. He ChaseDog31 04/28/22 09:15:05 PM
#19324   New corporate office is in Liverpool, NY, a ChaseDog31 04/28/22 09:09:06 PM
#19323   Sweet! https://www.otcmarkets.com/otcapi/company/financial-report/329564/conte Bivins 04/28/22 07:37:29 PM
PostSubject
Consent Preferences